Prior analysis of the CFH Y402H risk variant demonstrated it has reduced ability to inhibit complement activation, thereby leading to increased C3a and C3b, potentially contributing to the strong association between chronic inflammation and AMD initiation and progression [12]. The gene discussed is C3; the disease is age-related macular degeneration.